Ad
related to: astrazeneca group
Search results
This Pharma Stock Is Poised to Keep Outperforming the S&P 500 | The Motley Fool
The Motley Fool· 15 hours agoAstraZeneca (AZN 0.91%), recognized as the world's sixth-largest pharmaceutical entity by market...
Here's Why We Think AstraZeneca (LON:AZN) Is Well Worth Watching
Simply Wall St. via Yahoo Finance· 7 days agoBig buys like that may signal an opportunity; actions speak louder than words. Along with the...
Parallel Advisors LLC Sells 169 Shares of AstraZeneca PLC (NASDAQ:AZN)
ETF DAILY NEWS· 15 hours agoParallel Advisors LLC reduced its stake in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 1.2% during the fourth quarter, according to the company in its most recent 13F filing ...
AstraZeneca (LON:AZN) Earns “Buy” Rating from Shore Capital
ETF DAILY NEWS· 7 days agoShore Capital reissued their buy rating on shares of AstraZeneca (LON:AZN – Free Report) in a research report report published on Tuesday morning, Marketbeat Ratings reports ...
Goldman Sachs Says Buy European Pharma Stocks Touting Innovation
Bloomberg via Yahoo Finance· 18 hours ago(Bloomberg) -- European drugmakers that are focused on building portfolios of new medicines have...
Journey to the center of the mirth
Politico· 16 hours agoSTALL-A-PALOOZA...delegates than the Ukrainians, who outnumbered even the American presence on the show floor. The third-largest group came from Czechia, followed by Italy ...
AstraZeneca-Daiichi's Enhertu follow-up Dato-DXd unable to prove overall survival benefit in phase 3
FierceBiotech· 3 days agoDaiichi Sankyo and antibody-drug conjugate (ADC) partner AstraZeneca have already filed their...
AstraZeneca, Merck, GSK Struck Record $44.1B Licensing Deals With Chinese Drugmakers In 2023: Report...
Benzinga· 4 days agoWestern pharmaceutical companies and investors are driving a record number of licensing deals with...
Here's Why Astrazeneca (AZN) is a Strong Growth Stock
Zacks via Yahoo Finance· 4 days agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
Feds plan for smoother access to RSV infant shot
Politico· 1 day agoWhat’s next: There still could be surprises. A manufacturing insider familiar with AstraZeneca’s production efforts granted anonymity to speak candidly about the upcoming ...
